This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 1999 Aug 28;319(7209):575-6.

doi: 10.1136/bmj.319.7209.575a.

The end of the heparin pump? Dosage regimens for low molecular weight heparins differ

M Lloyd

PMID: 10463911
PMCID: PMC1116449
DOI: 10.1136/bmj.319.7209.575a

Comment

The end of the heparin pump? Dosage regimens for low molecular weight heparins differ

M Lloyd. BMJ. 1999.

. 1999 Aug 28;319(7209):575-6.

doi: 10.1136/bmj.319.7209.575a.

Author

M Lloyd

PMID: 10463911
PMCID: PMC1116449
DOI: 10.1136/bmj.319.7209.575a

No abstract available

PubMed Disclaimer

Comment on

The end of the heparin pump? Low molecular weight heparin has many advantages over unfractionated heparin.
Grubb NR, Bloomfield P, Ludlam CA. Grubb NR, et al. BMJ. 1998 Dec 5;317(7172):1540-2. doi: 10.1136/bmj.317.7172.1540. BMJ. 1998. PMID: 9836650 Free PMC article. No abstract available.

Similar articles

The end of the heparin pump? Low molecular weight heparin has many advantages over unfractionated heparin.
Grubb NR, Bloomfield P, Ludlam CA. Grubb NR, et al. BMJ. 1998 Dec 5;317(7172):1540-2. doi: 10.1136/bmj.317.7172.1540. BMJ. 1998. PMID: 9836650 Free PMC article. No abstract available.
Past, present, and future perspectives of heparins in clinical settings and the role of impaired renal function.
Harenberg J. Harenberg J. Int J Cardiol. 2016 Jun;212 Suppl 1:S10-3. doi: 10.1016/S0167-5273(16)12003-0. Int J Cardiol. 2016. PMID: 27264865 Review.
Unfractionated heparin nomograms: are we following the evidence?
Sado DM, Price D, Sarvananthan S. Sado DM, et al. Br J Hosp Med (Lond). 2008 Nov;69(11):656. Br J Hosp Med (Lond). 2008. PMID: 19086128 No abstract available.
The importance of initial heparin treatment on long-term clinical outcomes.
Shojania AM. Shojania AM. Arch Intern Med. 1998 Jun 8;158(11):1270-2. doi: 10.1001/archinte.158.11.1270-a. Arch Intern Med. 1998. PMID: 9625408 No abstract available.
[Therapy of venous thromboembolism with low-molecular-weight heparins].
Haas S, Haas P, Creutzig A. Haas S, et al. Vasa. 2000 Feb;29(1):5-10. doi: 10.1024/0301-1526.29.1.5. Vasa. 2000. PMID: 10731882 Review. German.

See all similar articles

References

1. Grubb NR, Bloomfield P, Ludlam CA. The end of the heparin pump? BMJ. 1998;317:1540–1542. - PMC - PubMed
1. Grubb NR, Bloomfield P, Ludlam CA. The end of the heparin pump? BMJ. 1998;317:1540–1542. - PMC - PubMed
1. Vandermeulen EP, Van Aken H, Vermylen J. Anticoagulants and spinal-epidural anaesthesia. Anesth Analg. 1994;79:1165–1177. - PubMed
1. Wysowski DK, Talaricol L, Bacsanyi J, Botstein P. Spinal and epidural haematoma and low-molecular-weight heparin. N Engl J Med. 1998;338:1774–1775. - PubMed
1. Bullingham A, Strunin L. Prevention of postoperative venous thromboembolism. Br J Anaesth. 1995;75:622–630. - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information